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ABSTRACT 
The high risk of human papillomavirus (HPV) have already known widely and accepted as a 
causative agent for cervical cancer. Epidemiologically, predominant high-risk is HPV-16 and squamous cell 
carcinomas (SCC) is the most common histological type. HPV genotype probably correlates to histologic 
type. This study aims to determine how many fold is the risk of SCC on HPV-16 infection. This is a case 
control with SCC HPV-16 positive as the cases and SCC HPV-16 negative as the controls. Tissues diagnosed 
as SCC and non SCC was paraffin-embedded. SPF-10 and specific E7-primer types by LiPA were employed 
for genotyping of HPV-16. was applied to analyze the correlation. A number of 65 SCC consisted of 33 
cases and 32 controls were observed in this study. The risk of SCC on HPV-16 infection was 3.40-fold (95% 
CI = 1.44-8.03; p = 0.004) compare with HPV-16 negative. Controls in this study consist of 18 (27.69%) of 
HPV-18, 9 (13.85%) of HPV-52, and 5 (7.69%) of other HPV types. The mean-age of case group and control 
group infected by HPV were 52.28 ± 12.43 and 47.70 ± 8.02 year, respectively (p = 0.02). HPV-16 infection 
caused SCC is 3.5 more than other high risk group.  
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INTRODUCTION 
Cancer still becoming health problems worldwide 
and cervical cancer is the second most common 
cancer in women in developing countries where 80-
90% of cases occur.
1,2,3
  Cervical cancer also remains 
the leading cause of mortality in developing 
countries.
4,5
 The high risk of HPV have been well 
established as causative agent for cervical cancer. It 
can be detected in about 90% of all cervical 
cancers.
5,6,7
 More than 100 different genotypes of 
HPVs have been identified.
2
 The two predominant 
high-risk HPV types are HPV-16 and 18 associated with 
more than 90% of cervical cancers.
5,7,8
 Squamous cell 
carcinomas (SCC) and adenocarcinoma were the first 
and second most common histologic types of the 
cervical cancer.
1,8
 Several HPV genotypes may cause 
differentially progress from low-grade squamous 
intraepithelial lesion (LSIL) to malignancy so that HPV 
genotype may have potential use to predict the risk of 
cancer.
9
 
Many study found that HPV-16 is more prevalent 
in SCC whereas HPV-18 is more prevalent in 
adenocarcinoma. The purpose of this study was to 
know the risk developing cervical SCC infected by HPV-
16.  
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MATERIAL AND METHODS 
Data and specimen collection 
This study was case-control study that was 
conducted during the years 2011-2012.  As the 
material of this study were the paraffin-embedded 
tissue which have been diagnosed as cervical cancer at 
Department of Anatomical Pathology Faculty of 
Medicine Udayana University.  
 
HPV DNA detection and typing 
Paraffin-embedded tissue from cervical biopsies 
was sent for detection and genotyping of HPV DNA by 
PCR-based methods at Department of Pathology, 
Leiden University Medical Centre, the Netherland and 
Molecular Biology Unit, Faculty of Medicine, Udayana 
University. HPV DNA was detected in 2 steps. In the 
first step, the SPF10 primers at several dillution were 
used to amplify the DNA. In the second step, the 
positive products was performed using specific probes 
type-specific E7 primer by LiPA which detected 25 HPV 
types to know the evidence of HPV-16 or other types. 
A total of 185 cervical cancer biopsies were included in 
this study.  
The samples of this study were SCC consist of 
case subjects i.e. women with SCC who infected by 
HPV-16 and control subjects i.e. women with SCC who 
infected by other types of HPV. 
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Statistical analysis 
A 2 x 2 table was created and Pearson’s 
2
 test 
was applied. Statistical significance for these tests was 
set at the 2-sided of 0.05 levels. Bivariate analysis was 
employed to calculate odds ratios (ORs) for the risk of 
cervical SCC associated with HPV-16 with 95% 
confidence intervals (CIs). 
 
RESULTS 
The mean-age and risk of developing SCC 
associated with HPV-16 display in Table 1 and 2. 
Table 1 
Mean-age of Case and Control Group 
 
 
Case (n = 33) Control (n = 32) 
p* 
Mean SD Mean SD 
 
Age 
(years) 
 
52.28 
 
12.43 
 
47.70 
 
8.02 
 
0.02 
*significant p < 0.05 
SD = standard deviation 
 
The mean-age of case group infected by HPV was 
52.28 ± 12.43 and control group was 47.70 ± 8.02 
(p=0.02). This mean-age was statistically significant 
different. The youngest patient infected by HPV-16 
was 29 years old and the oldest patient was 80 years 
old. Table 2 displays the presence of HPV-16 infection 
was statistically significant associated with an increase 
of 3.40-fold in the risk of SCC compared with women 
who had SCC infected by other HPV types (95% CI = 
1.44-8.03; p = 0.004).  
 
 
DISCUSSION 
A total of 185 cervical cancer samples were 
included in this study. Of these, the overall HPV DNA 
prevalence was 108 (58.38%) and 77 (41.62%) were 
negative for HPV DNA. Some study found overall HPV 
prevalence was 90-98% in cervical cancer.
4,10,11
 
A total of 15 different HPV types were detected, but 
HPV-16 and 18 were the first and the second most 
common types. These two types were present in 56.48 
% of the patients. Other HPV types were 11, 31, 33, 
35, 39, 45, 51, 52, 53, 54, 58, 59, and 66. Several study 
also found HPV-16 and 18 as the first (57.4%) and the 
second (16.6%) most common types.
2,12,13
 Study by 
Helena et al (2009) found more than 90 per cent of 
cases were HPV-16, 18, 31, and 45, and  about half of 
these cases were infected by HPV-16.
14,15
 In Jakarta, 
Indonesia, HPV infection was found 95,9% in patient 
with cervical carcinoma. The most common type were 
HPV-16 (35%) and HPV-18 (28%).
16 
Study by 
Schellekens (2004) found the three most common 
types were HPV-16 (44%), 18 (39%) and 52 (14%).
4
 
Study in three regions in Indonesia, Jakarta, 
Tasikmalaya and Bali found the most prevalent types 
were HPV-52 (23,2%), HPV-16 (18%), HPV-18 (16,1%) 
and HPV-39 (11,8%). In Bali the most prevalent types 
were HPV-52 (18%), HPV-16 (15%) and HPV-18 
(12%).
17
 Of the 108 specimens positive for HPV DNA, 
42 (38.89%) diagnosed histopathologically as 
adenocarcinoma, 65 (60.19%) were SCC and 1 (0.92%) 
was adenosquamous carcinoma. About 90% of cervical 
cancer was squamous cell carcinoma origin from 
squamous metaplastic epithelium at transformation 
zone, the remain 10% was adenocarcinoma origin 
from cylindrical epithelium of endocervix.
1 
 
Table 2 
Correlation between HPV-16 to SCC 
 
  Squamous cell carcinoma 
OR CI p 
  Positive Negative 
 Positive 33 10    
HPV16    3.40 1.44-8.30 0.004 
 Negative 32 33    
 
 
The mean-age of case group infected by HPV was 
52.28 ± 12.43 and control group was 47.70 ± 8.02 
(p=0.02). The youngest patient infected by HPV-16 
was 29 years old and the oldest patient was 80 years 
old. Study by Xavier et al (2004) found HPV-16 was 
detected slightly more frequently in women older 
than 50 years than in women aged 50 years or 
younger among HPV-positive case patients, 62% and 
46%, respectively, whereas HPV-18 was more 
frequently detected in younger case patients than in 
older patients, 46% and 26%, respectively.
8
 
 
 
 
In this study HPV-16 was more common in squamous 
cell carcinoma 33 (78.57%) than in adenocarcinoma 9 
(21.43%). The statistically significant result also found 
by Nubia et al (2004) 54.4% vs 41.6% for HPV-16 and 
37.3% vs 11.3% for HPV-18. 
2  
Other study by Xavier et 
al (2004) found the same results, the prevalence of 
HPV-18 in adenocarcinomas (39%) is statistically 
significantly greater (p<0.001) than that in SCC (18%).
8
 
The prevalence of HPV-16 is increased in SCC 
compared to normal cytology, whereas HPV-18 is 
more prevalent in adenocarcinoma and its 
precursor.
18,19 
HPV-18 is the most prevalent type in 
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cervical adenocarcinomas (55%), followed by HPV-16 
(32%) and HPV-45 (10%).
11,14
 
Risk of developing SCC associated with HPV-16 in 
this study was statistically significant with an 3.40-fold 
increase (95% CI = 1.44-8.03; p = 0.004). Study by 
Xavier et al (2004) and Bulk et al (2006) found that 
HPV-16 confers the greatest risk for SCC.
18
 HPV-16 was 
associated most strongly with SCC (ORs 30; 95% CI, 12-
77).
 20
 
 
CONCLUSION 
Infection by HPV-16 was statistically significant 
associated with an 3.5-fold increase in the risk of 
cervical SCC (95% CI = 1.44-8.03; p = 0.004).  
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